Quadrant Capital Group LLC Igm Biosciences, Inc. Transaction History

Quadrant Capital Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$13.74 - $25.76 $1,593 - $2,988	-116 Reduced 54.72%	96 $1,000
Q4 2022 Feb 10, 2023	BUY	$15.45 - $26.02 $1,792 - $3,018	116 Added 120.83%	212 $3,000
Q2 2022 Aug 09, 2022	SELL	$13.27 - $25.5 $1,021 - $1,963	-77 Reduced 44.51%	96 $2,000
Q1 2022 May 06, 2022	BUY	$13.42 - $29.73 $2,321 - $5,143	173 New	173 $5,000
Q4 2021 Feb 01, 2022	SELL	$27.59 - $66.39 $744 - $1,792	-27 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$65.76 - $90.65 $1,775 - $2,447	27 New	27 $2,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.